Pfizer
By Ruth UmohFebruary 2, 2026
SuccessPfizer CEO Albert Bourla’s best leadership advice: Being optimistic is better than being right
By Preston ForeJanuary 31, 2026
C-Suite‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
By Nick LichtenbergJanuary 30, 2026
C-SuitePfizer CEO says he used ‘emotional blackmail’ to get employees to achieve impossible goals during COVID-19
By Eva RoytburgJanuary 29, 2026
C-SuitePfizer CEO on how he struck a deal with President Trump in 10 days to lower American drug costs
By Fortune EditorsJanuary 27, 2026
LawPfizer strikes $70B deal with Trump to cut Medicaid drug prices, expand American manufacturing under tariff threat
By Tom Murphy, Michelle S. Price and The Associated PressSeptember 30, 2025
SuccessCEO says his son is among Gen Zers questioning whether a college degree is worth it: ‘Is this education a scam?’
By Nino PaoliSeptember 17, 2025
By Olivia Fletcher, Stephen Carroll and BloombergJune 23, 2025
PoliticsCourt rejects European Commission’s refusal to share texts between von der Leyen and Pfizer CEO during COVID pandemic
By Sam McNeil and The Associated PressMay 15, 2025
NewslettersPfizer CEO Albert Bourla sees ‘a scientific renaissance’ in the U.S. amid backdrop of political threats to the future of research
By Diane BradyApril 24, 2025
CommentaryThe faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck
By Jeffrey Sonnenfeld and Steven TianFebruary 5, 2025
HealthPfizer CEO had dinner with RFK Jr.: ‘I’m cautiously optimistic’ in spite of his history with vaccines
By Hallie SteinerFebruary 4, 2025
By Bloomberg and Damian GardeFebruary 4, 2025
Most Popular
